The prostacyclin analogue beraprost sodium prevents occlusion of bypass grafts in patients with lower extremity arterial occlusive disease: a 20-year retrospective study

Annals of Vascular Surgery

Volumn 19, Issue 6, 2005, Pages 838-842

  Murakami, Mikiko ^a   Watanabe, Masazumi ^a   Furukawa, Hitoshi ^a   Nakahara, Hideki ^a  

^a TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; CILOSTAZOL; PROSTACYCLIN DERIVATIVE; SARPOGRELATE; WARFARIN;

ADULT; AGED; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FEMOROPOPLITEAL BYPASS; GRAFT FAILURE; GRAFT OCCLUSION; GRAFT PATENCY; HUMAN; KAPLAN MEIER METHOD; LEG; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE;

EID: 27644475263     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-005-7668-9     Document Type: Article

References (13)

1. Michaels J. Second European Consensus Document on Chronic Critical Limb Ichaemia. Eur J Vasc Surg 1993;7:223.
2. Quinones-Baldrich WJ, Prego AA, Ucelay-Gomez R, et al. Long-term results of infrainguinal revascularization with polytetrafluoroethylene: a ten-year experience. J Vasc Surg 1992;16:209-217.
3. Abbott WM, Green RM, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. J Vasc Surg 1997;25:19-28.
4. Klinkert P, Post PP, Breslau PP, et al. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004;27:357-362.
5. Miyazaki K, Nishibe T, Saya F, et al. Prosthetic grafts for above-knee femoropopliteal bypass. Int Angiol 2002;21:145-151.
6. Sala F, Hassen-Khodja R, Levis A, et al. Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts. Ann Vasc Surg 2003;17:401-407.
7. 2 analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group. Circulation 2000;102:426-431.
8. 2 analogue: a double-blinded, randomized, controlled trial. J Am Coll Cardiol 2003;41:1687-1689.
9. 2 analogue. J Endocrinol 2002;175:217-223.
10. Shinzinger H, Silberbauer K, Auerswald W. Prostacyclin formation by rat endothelial layer. Thromb Haemost 1980:43:229.
11. Perktold K, Leuprecht A, Prosi M, et al. Fluid dynamics, wall mechanics, and oxygen transfer in peripheral bypass anastomosis. Ann Biomed Eng 2002;30:447-460.
12. Mark DA, Alonso DR, Trac-Goldman K, et al. Effects of nutrition on disease and life span. II: Vascular disease serum cholesterol, serum thromboxane, and heart-produced procyclin in MRL mice. Am J Pathol 1984;117. 125-131.
13. 2 production: correlation with changes in human aortic atherosclerotic disease. Arteriosclerosis 1984;4:70-78.